Topical Ibuprofen for Delayed Onset Mulscle Soreness

Completed · Phase 3 · Has a placebo group

Conditions studied: Pain

In brief

The objective of this study is to compare the efficacy and safety of Ibuprofen 5% Topical Gel versus placebo administered two or three times daily for the treatment of pain associated with delayed onset muscle soreness following intense eccentric exercise of the elbow flexor muscles.

Key facts

Study ID

NCT01794923

Run by

Pfizer

People needed

205

Starts

2013-06-13

Expected to finish

2014-03-29

Last updated by the study team

2021-09-30

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males or females, 18 to 65 years of age, who have not engaged in upper extremity fitness activities for a minimum of 3 months prior to entry in the study; subjects must be willing to refrain from use of pharmacologic or non pharmacologic treatments (ie, heat, ice, massage) and other forms of soreness relief during the study

You may not qualify if…

• Use of corticosteroids or short- or long-acting non-steroidal anti-inflammatory drugs

Where it is running

• Institute for Applied Pharmaceutical Research — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.